The present invention provides a novel macrocyclic prodrug compound of general Formula (I), a pharmaceutical composition comprising a compound of Formula (I), and a method for treating diseases mediated by HDAC enzymes by administering a compound of Formula (I), wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, A and Z are defined herein.本發明提供通式(I)之新穎巨環前藥化合物、包含式(I)化合物之醫藥組合物及藉由投與式(I)化合物治療由HDAC酶介導之疾病之方法,其中R1、R2、R3、R4、R5、R6、R7、R8、R9、R10、R11、A及Z於本文中定義。